Medical/Pharmaceuticals
Onward Therapeutics Made a Second Strategic Equity Investment in Emercell for Their NK Cell Technology in Cancer Immunotherapy
EPALINGES, Switzerland and MONTPELLIER, France, June 20, 2022 /PRNewswire/ -- Onward Therapeutics SA (Onward Therapeutics) and Emercell SAS (Emercell) announced today the recent exercise of Onward Therapeutics' second of three instalments of equity investment in Emercell. With this investment, On...
2022-06-20 12:00
2676
SoniVie receives IDE approval from FDA for its Pilot study to treat Hypertension with its Renal Artery Denervation TIVUS™ technology
TEL AVIV, Israel, June 20, 2022 /PRNewswire/ -- SoniVie, an Israeli company developing a novel proprietary Therapeutic Intra-Vascular Ultrasound System (TIVUS™) to treat a variety of hypertensive disorders, announced that on May 5th 2022 the U.S. Food and Drug Administration granted IDE approval ...
2022-06-20 10:00
3222
Casio to Release Dermatology Camera and Scope in Europe
Following Completion of EU Declaration of Conformity to European MDR TOKYO, June 17, 2022 /PRNewswire/ -- Casio Computer Co., Ltd. announced today that the DZ-D100 Dermatology Camera and DZ-S50 Dermatology Scope conformity studies for European Medical Device Regulations (MDR) have been completed ...
2022-06-17 09:00
2586
Global Cord Blood Corporation Announced Cellenkos Receives FDA Clearance of IND Application for CK0804 as Add on Therapy to Ruxolitinib for the Treatment of Myelofibrosis
HONG KONG, June 17, 2022 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, is pleased to announce that Cellenkos, Inc. ("CLNK"...
2022-06-17 04:20
4435
Insilico Medicine appoints Dr. Feng Ren as co-CEO
Dr. Feng Ren, Chief Scientific Officer (CSO) and head of global research and development is named co-CEO of Insilico Medicine Highlights: * Insilico Medicine is a global, end-to-end, fully-integrated AI-powered biotechnology company with three business models: AI platform, collaboration, and ...
2022-06-16 21:03
5901
Global Cord Blood Corporation Announces Purported EGM Is Not Validly Convened
HONG KONG, June 16, 2022 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO, "GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, noticed that onJune 3, 2022 Blue Ocean Structure Inv...
2022-06-16 20:30
5722
New research reveals the critical actions needed to ensure COVID-19-driven surge in virtual health and care drives health access and equity in Asia
* COVID-19 pandemic triggered massive surge in virtual health and care delivery across the world, with regions includingAsia embracing hybrid virtual and in-person services * Report from the Broadband Commission for Sustainable Development Working Group on Virtual Health and Care – co-chair...
2022-06-16 15:45
2477
Global Pharmaceutical Market Drives Innovative Digitalization to Accelerate Drug Discovery
According to Frost & Sullivan, digitalization across the pharmaceutical value chain will improve the industry´s efficiency. SAN ANTONIO, June 16, 2022 /PRNewswire/ -- Frost & Sullivan's recent analysis, Global Pharmaceuticals Outlook, finds that the accelerated drug development timelines are driv...
2022-06-16 15:12
2588
Implantica Applauded by Frost & Sullivan for Transforming Gastroesophageal Reflux Disease Treatment with Its Revolutionary Implant RefluxStop™
The RefluxStop™ device prevents the regurgitation of stomach fluid into the esophagus and addresses the limitations of proton pump inhibitors (PPIs) and existing surgical methods and devices for treating acid reflux disease. SAN ANTONIO, June 16, 2022 /PRNewswire/ --– Frost & Sullivan recently a...
2022-06-16 14:00
2214
Sirnaomics Announces Publication of STP705 Clinical Study Results for Treatment of isSCC in the Peer-Reviewed Journal of Drugs in Dermatology
GAITHERSBURG, Md. and SUZHOU, China, June 16, 2022 /PRNewswire/ -- Sirnaomics Ltd. ("Sirnaomics", stock code: 2257.HK), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announced the peer-reviewed publication of Phase IIa clinical study results of its lead th...
2022-06-16 13:01
4043
GILEAD SCIENCES NEW DATA HIGHLIGHTS PEOPLE LIVING WITH HIV WHO ARE VIRALLY SUPPRESSED EXPERIENCE SIMILAR HEALTH-RELATED QUALITY OF LIFE AS GENERAL POPULATION
– Data in Taiwan Shows That Antiretroviral Therapies Have Helped Transform HIV Into a Chronic Condition and Bring Positive Change in the Outlook for People Living with HIV– SINGAPORE, June 16, 2022 /PRNewswire/ -- Gilead Sciences, Inc. today announced results from an online survey that assessed ...
2022-06-16 11:15
3021
Ascletis Announces Oral Presentation on Updates from Phase IIb Clinical Trial of ASC22, a Subcutaneous PD-L1 Antibody for Functional Cure of Chronic Hepatitis B at EASL ILC 2022
- The updates of ASC22 Phase IIb study will be presented at the oral session during the International Liver Congress™ 2022 onSaturday, June 25, 2022 at 14:15 , Beijing Time (Abstract Number: OS091) HANGZHOU, China and SHAOXING, China, June 16, 2022 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX:1672...
2022-06-16 08:10
3965
Novotech and Medidata expand partnership to continue advancements in clinical research
Leading Asia-Pacific biotech specialist CRO Novotech and Medidata renew partnership, further expanding services to Novotech clients in APAC and the US SINGAPORE, June 16, 2022 /PRNewswire/ -- Medidata, a Dassault Systèmes company, today announced its renewed, expanded partnership with Novotech, a...
2022-06-16 08:00
3432
Mindray Reimagines Point of Care Systems with Launch of New TEX20 Diagnostic Ultrasound Series at Euroanaesthesia 2022
SHENZHEN, China, June 15, 2022 /PRNewswire/ -- Mindray
2022-06-15 21:17
5475
AnchorDx's Non-invasive Lung Cancer Early Diagnosis Product, PulmoSeek, Completes EU CE Marking Requirements
The company obtained a European Access Permit for in-vitro diagnostics devices (IVDD) authorized by the Netherlands CIBG of Ministry of Health, Welfare and Sport. GUANGZHOU, China, June 15, 2022 /PRNewswire/ -- PulmoSeekTM Lung Cancer Early Detection Assay, the non-invasive blood-based cfDNA met...
2022-06-15 21:00
3389
Inteleos Tackles Global Maternal and Fetal Outcomes Through Ultrasound Proficiency Grand Challenge
Comprehensive ultrasound training and certification programs for low-resource communities aims to lower maternal and fetal mortality rates ROCKVILLE, Md., June 15, 2022 /PRNewswire/ -- Inteleos™, a non-profit global healthcare certification organization, is working to create partnerships in low-...
2022-06-15 21:00
2374
Clinical Study Collaborator HCL Sends First Surgically Excised Ovarian Cancer Tumors to BioVaxys for BVX-0918 Vaccine Process Development
VANCOUVER, BC, June 15, 2022 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company"), announced today that its clinical study collaborator Hospices Civils deLyon in France ("HCL") has surgically excised the first ovarian cancer tumors from cancer ...
2022-06-15 20:00
5424
Texas Cardiac Arrhythmia Institute at St. David's Medical Center hosted international conference on complex cardiac arrhythmias
AUSTIN, Texas, June 15, 2022 /PRNewswire/ -- On June 2 and 3, 2022, the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center hosted its sixth international symposium on complex arrhythmias, EPLive 2022. This year's event had more than 1,250 people register, a record number, wit...
2022-06-15 18:14
4255
European Wellness and ABH Group to Establish World-Class Anti-Aging, Longevity, and Disease Prevention Center in Santorini, Greece
ATHENS, Greece, June 15, 2022 /PRNewswire/ -- European Wellness International GMBH (EW Group) has signed a Joint Venture Agreement (JVA) with ABH Clinical Prevention and Age Management S.A. (ABH Group), joining forces to establish a medical, wellness, and aesthetic retreat center in the heart of ...
2022-06-15 17:09
4210
SENTINEL DIAGNOSTICS LAUNCHES A TOTALLY AUTOMATED HIGH THROUGHPUT ANALYZER FOR FECAL IMMUNOCHEMICAL TESTING
MILAN, June 15, 2022 /PRNewswire/ -- To fulfill the growing need of Colorectal Cancer Screening organizations and big clinical laboratories,Sentinel Diagnostics- an Italian company focused for more than 35 years on the development and production ofIn Vitro Diagnostics for the most advanced Clini...
2022-06-15 16:00
3165
Week's Top Stories
Most Reposted
Agoda Releases AI Developer Report 2026: Agentic AI Adoption Outpaces Enterprise Readiness Across Southeast Asia and India
[Picked up by 294 media titles]
2026-09-24 10:30
Malaysia Calls for Shift from Halal-Certified to Halal-Competitive as ASEAN Targets USD5 Trillion Global Halal Economy
[Picked up by 277 media titles]
2026-09-25 14:45
Responsible Fintech Institute Appoints Four Executive Fellows and Elevates Distinguished Professor Patrick H. M. Loh to Co-Founder
[Picked up by 276 media titles]
2026-09-29 09:00
HLB's Flagship CIO Fund Launched with Strategic Alliance with Lombard Odier
[Picked up by 276 media titles]
2026-09-28 23:04
Nuix Recognised as a RiskTech100® 2027 Disruptor by Chartis Research
[Picked up by 274 media titles]
2026-09-25 08:30Most Read
Brightray Signs Prefabricated Module Sales Framework Agreement for Planned 40MW AI Data Center Project in Macao
2026-09-25 20:30
13883
Envision Energy Secures TÜV SÜD Certificate for Wind Farm Control System, Strengthening Long-Term Resilience for Future Energy Systems
2026-09-25 20:11
12600
ULTRALOQ Launches Next-Generation Smart Lock Collection: Refining Home Entry with Natural, Intelligent and Trusted Access Solutions
2026-09-26 02:46
11636
